Idebenone for Primary Progressive Multiple Sclerosis

NCT01854359 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

61

Enrollment

NIH

Sponsor class

Conditions

Multiple Sclerosis
Primary Progressive Multiple Sclerosis

Interventions

DRUG: Idebenone

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)